Results 81 to 90 of about 32,366 (210)

Refractoriness, habituation, and mismatch effects in the auditory event-related potential to alternating stimuli

, 2008
Amplitude enhancement in the NI component of auditory event-related potentials (ERPs) to alternately presented sounds has been referred as a typical example for the effect of release from neural refractoriness.
YAĞCIOĞLU, SÜHA, Ungan, Pekcan
core   +1 more source

Effect of sodium dodecyl benzene sulfonate on vitrified bond and dispersion of diamond

Jin'gangshi yu moliao moju gongcheng, 2022
Vitrified bonds and the mixed powders of diamond and vitrified bonds are prepared by sol-gel and corresponding bulk composites are fabricated. The effect of mass fraction of dispersant (sodium dodecyl benzene sulfonate) ranged from 0 to 4.02% on property
Yibo LIU, Shuaifei KONG, Zhengxin LI, Qiang XU, Chunhui CHEN   +4 more
doaj  

Molecular subtyping combined with multiomics analysis to study correlation between TACE refractoriness and tumor stemness in hepatocellular carcinoma

Background Transarterial chemoembolization (TACE) refractoriness is a significant challenge in treating intermediate to advanced-stage hepatocellular carcinoma (HCC).
Xiaoyu Yang, Qifan He, Zhonghua Chen, Yue Xiong, Yihui Yu   +4 more
core   +1 more source

Refractoriness to inhaled sodium metabisulphite in subjects with mild asthma.

, 1994
Refractoriness occurs after challenges causing mediator release in asthma, by a mechanism which may involve inhibitory prostaglandins. Bronchoconstriction due to inhaled sodium metabisulphite is thought to involve neural pathways and to be independent of
Wisniewski, A, Pavord, ID, Tattersfield, AE   +2 more
core   +1 more source

Platelet antibody detection by flow cytometry: an effective method to evaluate and give transfusional support in platelet refractoriness

, 2013
BACKGROUND: Immune platelet refractoriness is mainly caused by human leukocyte antigen antibodies (80-90% of cases) and, to a lesser extent, by human platelet antigen antibodies.
Thayna Mendonca Avelino, Ana Claudia Goncalez, Carolina Bonet Bub, Beatriz Moraes Martinelli, Vagner Castro, Maria de Lourdes Barjas-Castro   +5 more
core   +1 more source

The immune cell dynamics in the peripheral blood of cHL patients receiving anti-PD1 treatment

Frontiers in Oncology
Checkpoint blockade therapy (CBT) involving anti-PD1 antibodies represents the standard approach for cHL patients who do not respond to second-line therapy. Nonetheless, only 20% of relapsed/refractory (R/R) cHL patients treated with CBT achieve complete
Vanessa Cristaldi, Lodovico Terzi di Bergamo, Lodovico Terzi di Bergamo, Lucrezia Patruno, Marinos Kallikourdis, Marinos Kallikourdis, Giada Andrea Cassanmagnago, Francesco Corrado, Eleonora Calabretta, Adalgisa Condoluci, Adalgisa Condoluci, Martina di Trani, Daoud Rahal, Gianluca Basso, Clelia Peano, Alex Graudenzi, Alex Graudenzi, Marco Antoniotti, Marco Antoniotti, Davide Rossi, Davide Rossi, Carmelo Carlo-Stella, Carmelo Carlo-Stella   +22 more
doaj   +1 more source

Unveiling the dynamics and molecular landscape of a rare chronic lymphocytic leukemia subpopulation driving refractoriness: insights from single‐cell RNA sequencing

Molecular Oncology
Early identification of resistant cancer cells is currently a major challenge, as their expansion leads to refractoriness. To capture the dynamics of these cells, we made a comprehensive analysis of disease progression and treatment response in a chronic
Terezia Kurucova, Kamila Reblova, Pavlina Janovska, Jakub Pawel Porc, Veronika Navrkalova, Sarka Pavlova, Jitka Malcikova, Karla Plevova, Boris Tichy, Michael Doubek, Vitezslav Bryja, Jana Kotaskova, Sarka Pospisilova   +12 more
doaj   +1 more source

Factors affecting refractoriness or recurrence in diffuse large B-cell lymphoma: development and validation of a novel predictive nomogram

Hematology
Background Relapsed/Refractory (R/R) diffuse large B-cell lymphoma (DLBCL) represents a subgroup with a high incidence and dismal prognosis. Currently, there is a lack of robust models for predicting R/R DLBCL.
Yiwei Guo, Jie Lian, Yao Chen, Lina Quan, Xiuchen Guo, Jingbo Zhang, Zhiqiang Liu, Aichun Liu   +7 more
doaj   +1 more source

Treatment of Patients with Relapsed/Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma: Own Data and Literature Review

Клиническая онкогематология
AIM. To determine the optimal strategy of chemotherapy for patients with relapsed/refractory (r/r) primary mediastinal (thymic) large B-cell lymphoma (PMBCL). MATERIALS & METHODS. The study is based on the clinical data from 26 patients with r/r PMBCL
Arman Vachakanovich Arakelyan, G. S. Tumyan, A. A. Semenova, M. Yu. Kichigina, I. Z. Zavodnova, D. N. Tupitsyna, E. V. Paramonova, A. S. Antipova, V. O. Shpirko, Yu. I. Klyuchagina, S. F. Ramazanova, U. G. Koshkina, I. S. Monin, N. M. Zolotaikina, G. D. Petrova, O. P. Trofimova, A. S. Subbotin, M. A. Senchenko, V. Yu. Kirsanov   +18 more
doaj   +1 more source

Dependency of calcium alternans on Ryanodine Receptor Refractoriness

Background Rapid pacing rates induce alternations in the cytosolic calcium concentration caused by fluctuations in calcium rele However, the relationship between calcium alternans and refractoriness of the SR calcium release channel (RyR2) Methodology ...
Echebarría Domínguez, Blas, Cinca, J., Peñaranda Ayllón, Angelina, Álvarez Lacalle, Enrique, Hove-Madsen, Leif, Rodríguez Cantalapiedra, Inma   +5 more
core